JMP Securities Issues Positive Forecast for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price
Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) had its target price upped by JMP Securities from $74.00 to $76.00 in a report released on Friday morning,Benzinga reports. The brokerage currently has a market outperform rating on the stock. A number of other research firms have also weighed in on MIRM. Robert W. Baird increased their price […]
